Rassol Laleau

565 total citations
6 papers, 245 citations indexed

About

Rassol Laleau is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Organic Chemistry. According to data from OpenAlex, Rassol Laleau has authored 6 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Oncology and 1 paper in Organic Chemistry. Recurrent topics in Rassol Laleau's work include Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and CAR-T cell therapy research (2 papers). Rassol Laleau is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and CAR-T cell therapy research (2 papers). Rassol Laleau collaborates with scholars based in United States. Rassol Laleau's co-authors include Ravi Chari, Jan Pinkas, Nicholas C. Yoder, Yulius Y. Setiady, Olga Ab, Chen Bai, Alan Wilhelm, Sharlene Adams, Yelena Kovtun and Lauren Harvey and has published in prestigious journals such as Cancer Research, Bioconjugate Chemistry and Molecular Cancer Therapeutics.

In The Last Decade

Rassol Laleau

6 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rassol Laleau United States	4	164	104	86	73	32	6	245
Lauren Harvey United States	6	179 1.1×	64 0.6×	88 1.0×	112 1.5×	45 1.4×	8	258
Alan Wilhelm United States	9	273 1.7×	154 1.5×	128 1.5×	104 1.4×	47 1.5×	22	388
Gabriel N. Waterman United States	7	187 1.1×	96 0.9×	118 1.4×	178 2.4×	60 1.9×	8	310
Kirsten Achilles Poon United States	6	180 1.1×	142 1.4×	74 0.9×	32 0.4×	40 1.3×	6	278
Kyle A. Udd United States	8	202 1.2×	99 1.0×	121 1.4×	197 2.7×	51 1.6×	25	307
Suzie Vardanyan United States	7	213 1.3×	120 1.2×	131 1.5×	223 3.1×	47 1.5×	20	322
Leanne Lanieri United States	7	179 1.1×	137 1.3×	86 1.0×	17 0.2×	33 1.0×	17	286
Turner Kufe United States	6	164 1.0×	40 0.4×	216 2.5×	128 1.8×	148 4.6×	7	368
Patrick H. van Berkel United Kingdom	9	393 2.4×	181 1.7×	112 1.3×	26 0.4×	96 3.0×	35	496
Frank Osterroth Germany	8	114 0.7×	94 0.9×	77 0.9×	69 0.9×	135 4.2×	11	250

Countries citing papers authored by Rassol Laleau

Since Specialization

Citations

This map shows the geographic impact of Rassol Laleau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rassol Laleau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rassol Laleau more than expected).

Fields of papers citing papers by Rassol Laleau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rassol Laleau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rassol Laleau. The network helps show where Rassol Laleau may publish in the future.

Co-authorship network of co-authors of Rassol Laleau

This figure shows the co-authorship network connecting the top 25 collaborators of Rassol Laleau. A scholar is included among the top collaborators of Rassol Laleau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rassol Laleau. Rassol Laleau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Ponte, Jose F., Leanne Lanieri, Eshita Khera, et al.. (2020). Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody–Drug Conjugates to Increase In Vivo Efficacy. Molecular Cancer Therapeutics. 20(1). 203–212. 29 indexed citations

2.

Bai, Chen, Alan Wilhelm, Erin K. Maloney, et al.. (2019). Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody–Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine Conjugation. Bioconjugate Chemistry. 31(1). 93–103. 20 indexed citations

3.

Kovtun, Yelena, Gregory E. Jones, Sharlene Adams, et al.. (2018). A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells. Blood Advances. 2(8). 848–858. 129 indexed citations

4.

Vitharana, Dilrukshi, Alan Wilhelm, Luke Harris, et al.. (2016). Abstract 2965: In vitro and in vivo activity of a site-specific SeriMab antibody-drug conjugate (ADC) using an indolino-benzodiazepine DNA-alkylating agent. Cancer Research. 76(14_Supplement). 2965–2965. 1 indexed citations

5.

Ponte, Jose F., Xiuxia Sun, Nicholas C. Yoder, et al.. (2016). Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody–Maytansinoid Conjugates. Bioconjugate Chemistry. 27(7). 1588–1598. 65 indexed citations

6.

Lai, Katharine C., Xiuxia Sun, Rassol Laleau, et al.. (2015). Abstract 4504: Plasma pharmacokinetics and tumor accumulation in mice of IMGN779, an antibody-drug conjugate for acute myeloid leukemia. Cancer Research. 75(15_Supplement). 4504–4504. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact